 Induction vitro graft-versus-leukemia activity bone marrow transplantation chronic myeloid leukemia vitro effects lymphokine-activated killer LAK cells peripheral blood chronic myeloid leukemia CML patients allogeneic syngeneic bone marrow transplantation BMT LAK cells peripheral blood mononuclear cells patients post-BMT recombinant U/mL AB serum days activity standard release assay CFU-GM assay LAK cells activated natural killer cells cells release assay LAK cells allogeneic syngeneic recipients recipient CML cells cases HLA disparate CML cells CFU-GM LAK cells CML cells liquid culture colony growth allogeneic syngeneic recipients Cell-cell contact necessary optimal effect little inhibition proliferation donor marrow CFU-GM vitro graft-versus-leukemia GVL effect LAK effectors cells inducible recipients cell-depleted cell-replete donor marrow recipients graft-versus-host disease results major histocompatibility complex-unrestricted GVL effect inducible allogeneic syngeneic BMT use cells BMT risk relapse